Capital World Investors’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-797,523
Closed -$917K 551
2022
Q4
$917K Hold
797,523
﹤0.01% 523
2022
Q3
$702K Sell
797,523
-802,477
-50% -$971K ﹤0.01% 535
2022
Q2
$1.79M Hold
1,600,000
﹤0.01% 526
2022
Q1
$2.22M Hold
1,600,000
﹤0.01% 550
2021
Q4
$5.46M Hold
1,600,000
﹤0.01% 571
2021
Q3
$14.1M Sell
1,600,000
-517,967
-24% -$6.81M ﹤0.01% 546
2021
Q2
$36M Hold
2,117,967
0.01% 482
2021
Q1
$28.3M Buy
2,117,967
+864,800
+69% +$19.5M 0.01% 494
2020
Q4
$36.1M Buy
1,253,167
+217,232
+21% +$5.88M 0.01% 439
2020
Q3
$30.9M Buy
+1,035,935
New +$31.4M 0.01% 427

Other funds holding AFIB

Capital World Investors's AFIB Position: Q1 2023 in Review

Capital World Investors sold out of Acutus Medical Inc (AFIB) in Q1 2023, closing a stake of 797,523 shares — an estimated $917K sold.

Capital World Investors first reported a position in AFIB in Q3 2020 and held it in 10 quarters. The position peaked at $36.1M in Q4 2020. 38 funds tracked by Wall St. Rank hold AFIB as of Q1 2023.

  • Capital World Investors reported no remaining Acutus Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Capital World Investors sold 797,523 Acutus Medical Inc shares in Q1 2023, an estimated $917K.
  • Capital World Investors first reported a position in Acutus Medical Inc in Q3 2020 and held it in 10 quarters.
  • Capital World Investors's Acutus Medical Inc position peaked at $36.1M in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2023.

Based on Capital World Investors's 13F filing for Q1 2023, filed 15 May 2023.